Novotech, an Asia Pacific centered biotech CRO will be at BIO Europe (March 20-22, 2023) to meet with clinical stage biotechs and to share the benefits of Novotech’s recently expanded operations in Europe.
Novotech announced the acquisition of EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program. EastHORN was established in 2004 and has over 250 employees.
Novotech has acquired EastHORN – a European contract research organisation (CRO) that specialises in clinical, medical and regulatory operations across Europe. The purchase represents part of Novotech's wider global expansion programme. EastHORN was established in 2004 and has over 250 employees.
Over the past few years, the CRO Novotech has cemented its position in the Asia-Pacific region, but its latest move will see it planting its flag on two different continents.
SINGAPORE, June 16, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a leading contract research organisation (CRO), to continue scaling clinical studies in various therapeutic areas from 2022.
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program. The expansion support biotech clinical services in the US to assist in later phase global studies.
That means Novotech can now offer services in the U.S., specifically for later-phase global studies, the company said Wednesday. Financial details of the transaction were not disclosed.
SYDNEY--(BUSINESS WIRE)--Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce a strategic partnership to combine the power of real world evidence and clinical trials to get medicines to patients faster. The partnership includes an investment by Novotech in Prospection.
While Novotech has a long history of helping international biotechs run clinical trials in Asia, PPC's clientele is mainly based in China.
The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea’s world-class 1,300-bed Pusan National University Hospital (PNUH) based in Busan, South Korea’s second largest city.